title: Anti-Nociceptive Effect of Resveratrol During Inflammatory Hyperalgesia via Differential Regulation of pro-Inflammatory Mediators.
abstract: Sensitization of nociceptive neurons by inflammatory mediators leads to hypersensitivity for normal painful stimuli which is termed hyperalgesia. Oxidative stress is an essential factor in pathological pain; therefore, antioxidants qualify as potential anti-hyperalgesic agents. The present study examines the efficacy of the natural antioxidant resveratrol in complete Freund's adjuvant (CFA) induced hyperalgesic rats. Thermal hyperalgesia was measured at different time points by paw withdrawal latency test and confirmed by c-Fos expression in spinal dorsal horn. The impact of resveratrol treatment on inflammatory mediators at peripheral (paw skin) and central (spinal cord) sites was determined during early (6 h) as well as late phase (48 h) of hyperalgesia. Intraplanter injection of CFA increased the level of cytokines IL-1β, TNF-α and IL-6 as well as inflammatory enzymes COX-2 and iNOS in paw skin in both phases. In case of spinal cord, the level of COX-2 was found to be elevated in both phases, whereas iNOS could not be detected. The cytokines were found to be elevated only in late phase in spinal cord. Administration of resveratrol (20 mg/kg) shifted the level of all inflammatory mediators towards normal, except cytokines in paw skin. The present study suggests that the anti-nociceptive effect of resveratrol is implicated at both peripheral and central sites in a tissue specific manner. Copyright © 2016 John Wiley & Sons, Ltd.
authors.affiliation: Biochemistry and Molecular Biology Laboratory, Centre for Advanced Study in Zoology, Banaras Hindu University, Varanasi, India.
authors.forename: Ajeet Kumar
authors.initials: AK
authors.lastname: Singh
authors.affiliation: Biochemistry and Molecular Biology Laboratory, Centre for Advanced Study in Zoology, Banaras Hindu University, Varanasi, India.
authors.forename: Manjula
authors.initials: M
authors.lastname: Vinayak
mesh_terms: D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D051546:Cyclooxygenase 2 / Q000032:analysis / Q000502:physiology; D016207:Cytokines / Q000032:analysis; D006930:Hyperalgesia / Q000188:drug therapy*; D018836:Inflammation Mediators / Q000032:analysis*; D008297:Male; D052247:Nitric Oxide Synthase Type II / Q000502:physiology; D051381:Rats; D000077185:Resveratrol; D013116:Spinal Cord / Q000187:drug effects / Q000276:immunology; D013267:Stilbenes / Q000494:pharmacology*
chemical_list: D000700:Analgesics; D016207:Cytokines; D018836:Inflammation Mediators; D013267:Stilbenes; D052247:Nitric Oxide Synthase Type II; C496318:Nos2 protein, rat; D051546:Cyclooxygenase 2; D000077185:Resveratrol
keywords: COX-2; IL-1β; IL-6; TNF-α; hyperalgesia; iNOS